Bitter Pills:Medicines & The Third World Poor | Page 84

Betnelan Tablet contains 0.5 mg betamethasone.

In majority

of ihese cases,

Recommended dosage for s h o r t - t e r m therapy
of Betnelan:
To start
(a) 2 tablets 3 times a day for first 2 days
Followed by (b) 1 tablet 3 times a day for next 2 days
,, (c) -: tablet 3 times a day for last 2 days

This extremely small dosage is effective and safe

tion and enables the patient to move more freely.

given over 6 days reduces the inflammatory condi-

great help. A short and safe course of 21 tablets

to inflammation. In these cases Betnelan can be of

but the mobility of the patient remains impaired due

though rheumatic pain is relieved with analgesic,

is fully established.

as bursitis, tenosynovitis, epicondylitis and synovitis

of Betnelan in rheumatic inflammatory disorder such

tions is already known and acknowledged. Usefulness

as eczema, urticaria, asthma and food and drug erup-

The value of Betnelan in allergic conditions such

0

1

Betnelan is indicated when
corticosteroid
therapy is required in a variety of conditions,
including acute asthma, intractable hay fever
and some inflammatory skin diseases. Other
indications include rheumatoid arthritis, the
nephrotic syndrome and various blood dyscrasias.

Betnelan has a negligible effect on potassium
balance.

Betnelan is virtually free from risk of causing
oedema and hypertension.

Betnelan is a corticosteroid and is about 8
to 10 times as potent as prednisolone on a
weight-tor-weight basis.